Welcome to our home for news – the latest headlines, all in one place. Click through to view a selection of our media coverage, industry news, videos and more.
Three Sofdra scientific posters were accepted and exhibited at leading dermatology continuing medical education (CME) conferences in October and early November 2025. CME is a trusted source of information for dermatologists.
We share the International Hyperhidrosis Society’s belief that ‘together, we can amplify the message that excessive, uncontrollable sweating is a serious medical condition warranting serious attention.’ Throughout November, Botanix will introduce new materials in dermatology offices to raise awareness of excessive underarm sweating and Sofdra® (sofpironium).
Chief Executive Officer Dr Howie McKibbon will present to institutional investors at today’s Canaccord Drug and Device Healthcare Conference in Noosa. For the balance of the week, Canaccord Genuity will host a Botanix investor roadshow.
The Quarterly Activity Report and 4C Quarterly Cash Flow Report for Q1 FY2026 have been released. Quarter over quarter, total prescriptions for Sofdra® (sofpironium) increased 50% to 20,418 as operating cash outflow decreased 54% to $13.1 million. Net revenue was $7.1 million.
Join our executive team for the Company’s Quarterly Activity Report and 4C Quarterly Cash Flow Report Webinar on Monday 20 October at 11.00 am AEDT / 8.00 am AWST for an important update.
Botanix Executive Chairman Vince Ippolito will be a featured presenter on Tuesday, 9 September at the HC Wainwright 27th Annual Global Investment Conference in New York, NY (US). This conference attracts institutional fund managers from around the world and some of the most promising global growth companies, including those in the healthcare and life sciences sectors.
https://botanixpharma.com/wp-content/uploads/HC-Wainwright.png8501600Haley Chartres/wp-content/uploads/botanix-logo.pngHaley Chartres2025-09-08 00:41:182025-09-08 00:41:18Botanix featured at global investor conference
Sofdra posters presented at dermatology conferences
/in Featured, Latest News, News /by Haley ChartresThree Sofdra scientific posters were accepted and exhibited at leading dermatology continuing medical education (CME) conferences in October and early November 2025. CME is a trusted source of information for dermatologists.
Read the full story.
Botanix Supports Hyperhidrosis Awareness Month
/in Featured, Latest News, News /by Haley ChartresWe share the International Hyperhidrosis Society’s belief that ‘together, we can amplify the message that excessive, uncontrollable sweating is a serious medical condition warranting serious attention.’ Throughout November, Botanix will introduce new materials in dermatology offices to raise awareness of excessive underarm sweating and Sofdra® (sofpironium).
Click to read media release.
Botanix Presents at Canaccord Conference
/in ASX Releases, Featured, Latest News, News /by Haley ChartresChief Executive Officer Dr Howie McKibbon will present to institutional investors at today’s Canaccord Drug and Device Healthcare Conference in Noosa. For the balance of the week, Canaccord Genuity will host a Botanix investor roadshow.
View ASX Release
Botanix Releases Quarterly Reports
/in ASX Releases, Featured, Latest News, News /by Haley ChartresThe Quarterly Activity Report and 4C Quarterly Cash Flow Report for Q1 FY2026 have been released. Quarter over quarter, total prescriptions for Sofdra® (sofpironium) increased 50% to 20,418 as operating cash outflow decreased 54% to $13.1 million. Net revenue was $7.1 million.
Click to view the Reports.
Quarterly Update Webinar October 20 | Registration Open
/in Featured, Latest News, News /by Haley ChartresJoin our executive team for the Company’s Quarterly Activity Report and 4C Quarterly Cash Flow Report Webinar on Monday 20 October at 11.00 am AEDT / 8.00 am AWST for an important update.
Participants must pre-register: Click here
Botanix featured at global investor conference
/in Featured, Latest News, News, Presentations /by Haley ChartresBotanix Executive Chairman Vince Ippolito will be a featured presenter on Tuesday, 9 September at the HC Wainwright 27th Annual Global Investment Conference in New York, NY (US). This conference attracts institutional fund managers from around the world and some of the most promising global growth companies, including those in the healthcare and life sciences sectors.
View ASX Release & Presentation.